The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration.

Implant osseointegration, defined as bone apposition and functional fixation, is a requisite for clinical success in orthopaedic and dental applications, many of which are restricted by implant loosening. Modification of implants to present bioactive motifs such as the RGD cell-adhesive sequence from fibronectin (FN) represents a promising approach in regenerative medicine. However, these biomimetic strategies have yielded only marginal enhancements in tissue healing in vivo. In this study, clinical-grade titanium implants were grafted with a non-fouling oligo(ethylene glycol)-substituted polymer coating functionalized with controlled densities of ligands of varying specificity for target integrin receptors. Biomaterials presenting the alpha5beta1-integrin-specific FN fragment FNIII 7-10 enhanced osteoblastic differentiation in bone marrow stromal cells compared to unmodified titanium and RGD-presenting surfaces. Importantly, FNIII 7-10-functionalized titanium significantly improved functional implant osseointegration compared to RGD-functionalized and unmodified titanium in vivo. This study demonstrates that bioactive coatings that promote integrin binding specificity regulate marrow-derived progenitor osteoblastic differentiation and enhance healing responses and functional integration of biomedical implants. This work identifies an innovative strategy for the rational design of biomaterials for regenerative medicine.

[1]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[2]  D. Collard,et al.  Controlling Cell Adhesion to Titanium: Functionalization of Poly[oligo(ethylene glycol)methacrylate] Brushes with Cell‐Adhesive Peptides , 2007 .

[3]  P. Coleman,et al.  Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis. , 2003, Journal of medicinal chemistry.

[4]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[5]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[6]  T. Bauer,et al.  The pathology of total joint arthroplasty.II. Mechanisms of implant failure. , 1999, Skeletal radiology.

[7]  R. Pilliar,et al.  Cementless implant fixation--toward improved reliability. , 2005, The Orthopedic clinics of North America.

[8]  H. Zwipp,et al.  In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  Benjamin G Keselowsky,et al.  Quantitative methods for analysis of integrin binding and focal adhesion formation on biomaterial surfaces. , 2005, Biomaterials.

[10]  Andrés J. García.  Get a grip: integrins in cell-biomaterial interactions. , 2005, Biomaterials.

[11]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[12]  Su‐Li Cheng,et al.  Regulation of αVβ3 and αVβ5 integrins by dexamethasone in normal human osteoblastic cells , 2000 .

[13]  L. Avioli,et al.  Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3. , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  S. M. Sims,et al.  Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. , 1999, Journal of cell science.

[15]  Andrés J. García,et al.  Biomolecular surface coating to enhance orthopaedic tissue healing and integration. , 2007, Biomaterials.

[16]  K. Miyazono,et al.  Focal Adhesion Kinase Activity Is Required for Bone Morphogenetic Protein—Smad1 Signaling and Osteoblastic Differentiation in Murine MC3T3‐E1 Cells , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Benjamin G. Keselowsky,et al.  Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Jeffrey A Hubbell,et al.  Biomaterials science and high-throughput screening , 2004, Nature Biotechnology.

[19]  T. Bauer,et al.  The pathology of total joint arthroplasty. I. Mechanisms of implant fixation. , 1999, Skeletal radiology.

[20]  S. Hanks,et al.  Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. , 2003, Frontiers in bioscience : a journal and virtual library.

[21]  K. Healy,et al.  Peri-implant bone formation and implant integration strength of peptide-modified p(AAM-co-EG/AAC) interpenetrating polymer network-coated titanium implants. , 2007, Journal of biomedical materials research. Part A.

[22]  M A Horton,et al.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. , 1997, The Journal of clinical investigation.

[23]  C. Carron,et al.  Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone. , 2000, The Journal of endocrinology.

[24]  P. Tengvall,et al.  Platelet binding and protein adsorption to titanium and gold after short time exposure to heparinized plasma and whole blood. , 1996, Biomaterials.

[25]  J. Jansen,et al.  In vivo evaluation of the trabecular bone behavior to porous electrostatic spray deposition-derived calcium phosphate coatings. , 2007, Clinical oral implants research.

[26]  Andrés J. García,et al.  Cell adhesion strengthening: contributions of adhesive area, integrin binding, and focal adhesion assembly. , 2005, Molecular biology of the cell.

[27]  N. Wright,et al.  In Vitro andIn Vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene , 2001, Calcified Tissue International.

[28]  Jörg Meyer,et al.  Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. , 2002, Clinical Oral Implants Research.

[29]  Catherine D Reyes,et al.  A centrifugation cell adhesion assay for high-throughput screening of biomaterial surfaces. , 2003, Journal of biomedical materials research. Part A.

[30]  Jeffrey R Capadona,et al.  Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. , 2006, Biomaterials.

[31]  James M. Anderson,et al.  Biological Responses to Materials , 2001 .

[32]  Su‐Li Cheng,et al.  Bone Mineralization and Osteoblast Differentiation Are Negatively Modulated by Integrin αvβ3 , 2001 .

[33]  N. Wright,et al.  In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. , 2001, Calcified tissue international.

[34]  Myron Spector,et al.  Early bone apposition in vivo on plasma-sprayed and electrochemically deposited hydroxyapatite coatings on titanium alloy. , 2006, Biomaterials.

[35]  Kjeld Søballe,et al.  In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. , 2005, Biomaterials.